Cempra Inc. (NASDAQ:CEMP) traded down 1% during mid-day trading on Friday . The stock traded as low as $21.80 and last traded at $22.06, with a volume of 286,166 shares. The stock had previously closed at $22.29.

Several equities research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Cempra from a “buy” rating to a “hold” rating in a research note on Thursday, August 11th. Needham & Company LLC restated a “buy” rating and issued a $48.00 price objective on shares of Cempra in a research note on Wednesday, August 3rd. Cowen and Company restated a “buy” rating on shares of Cempra in a research note on Tuesday, August 2nd. Robert W. Baird restated an “outperform” rating and issued a $33.00 price objective on shares of Cempra in a research note on Tuesday, August 2nd. Finally, Jefferies Group reduced their target price on Cempra from $42.00 to $40.00 and set a “buy” rating for the company in a research report on Tuesday, August 2nd. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Cempra has an average rating of “Buy” and an average price target of $35.17.

The stock’s 50-day moving average price is $20.95 and its 200 day moving average price is $18.31. The company’s market capitalization is $1.15 billion.

Cempra (NASDAQ:CEMP) last posted its earnings results on Monday, August 1st. The company reported ($0.51) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.16. The business had revenue of $3.42 million for the quarter, compared to analyst estimates of $3.89 million. During the same period in the previous year, the firm posted ($0.57) earnings per share. The firm’s revenue was down 33.3% compared to the same quarter last year. Equities analysts anticipate that Cempra Inc. will post ($2.63) EPS for the current year.

An institutional investor recently raised its position in Cempra stock. Ameriprise Financial Inc. raised its position in Cempra Inc. (NASDAQ:CEMP) by 78.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,281 shares of the company’s stock after buying an additional 27,438 shares during the period. Ameriprise Financial Inc. owned about 0.14% of Cempra worth $1,939,000 as of its most recent filing with the SEC.

Cempra, Inc is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic staphylococcal infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.